4.6 Editorial Material

Impact of aging in cancer immunotherapy The importance of using accurate preclinical models

Journal

ONCOIMMUNOLOGY
Volume 2, Issue 12, Pages -

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/onci.27186

Keywords

aging; cancer immunotherapy; inflammation; macrophage; organ damage; pro-inflammatory cytokines; TNF alpha

Ask authors/readers for more resources

Cancer immunotherapy holds great promise, yet its efficacy and applicability can be hampered by the rise of systemic toxicities. We have recently shown that the lethal side effects of cancer immunotherapy are markedly exacerbated with aging. Blocking tumor necrosis factor alpha or macrophages can alleviate the systemic toxicity of immunotherapy while preserving its antineoplastic effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available